Evidence map›Paper›PMID 37445501›Full record

ArticleJournal of clinical medicine2023

Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation: Retrospective Cohort Study.

Sami Akbulut, Fatma Hilal Yagin, Tevfik Tolga Sahin, Ibrahim Umar Garzali, Adem Tuncer, Musap Akyuz, Nazlican Bagci, Bora Barut, Selver Unsal, Kemal Baris Sarici and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 2 countries.

Sami AkbulutDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-6864-7711
Fatma Hilal YaginDepartment of Biostatistics and Medical Informatics, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-9848-7958
Tevfik Tolga SahinDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-9132-6115
Ibrahim Umar GarzaliDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-9797-851X
Adem TuncerDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Musap AkyuzDepartment of Surgical Nursing, Inonu University Faculty of Nursing, Malatya 44280, Turkey.
Nazlican BagciDepartment of Surgical Nursing, Inonu University Faculty of Nursing, Malatya 44280, Turkey.ORCID 0000-0001-8914-5465
Bora BarutDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Selver UnsalDepartment of Nursing Service, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Kemal Baris SariciDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Serdar SaritasDepartment of Surgical Nursing, Inonu University Faculty of Nursing, Malatya 44280, Turkey.ORCID 0000-0003-4076-9001
Ali OzerDepartment of Public Health, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-7144-4915
Recep BentliDepartment of Internal Medicine, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Cemil ColakDepartment of Biostatistics and Medical Informatics, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0001-5406-098X
Yasar BayindirDepartment of Infectious Diseases and Clinical Microbiology, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0003-3930-774X
Sezai YilmazDepartment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.ORCID 0000-0002-8044-0297
Inonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn liver transplant (LT) recipients, immunosuppressive therapy may potentially increase the risk of severe COVID-19 and may increase the mortality in patients. However, studies have shown conflicting results, with various studies reporting poor outcomes while the others show no difference between the LT recipients and healthy population. The aim of this study is to determine the impact of the COVID-19 pandemic on survival of LT recipients.

methodsThis is a retrospective cohort study analyzing the data from 387 LT recipients diagnosed with COVID-19. LT recipients were divided into two groups: survival (

resultsThe COVID-19-related mortality rate in LT recipients was 7.2%. Multivariate analysis showed that everolimus use (

conclusionThe effect of COVID-19 infection on LT recipients is slightly different from the effect of the disease on the general population. The COVID-19-related mortality is lower than the general population and vaccination for COVID-19 significantly reduces the risk of mortality.

Indexed as

COVID-19 pandemicCOVID-19 vaccineimmunosuppressive agentsliver transplantation

Identifiers

PMID37445501
PMCPMC10342746
OpenAlexW4383068568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.